Get PT-141 (Bremelanotide) Online in Ohio | OmniRx Health

Sexual Wellness Treatment in Ohio

PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.

Key Benefits

Works through the brain to enhance desire and arousal
Effective for both men and women
Addresses root causes of low libido rather than just physical response
FDA-approved active ingredient (Vyleesi for women)
Unique central mechanism distinct from PDE5 inhibitors

Who is a Good Candidate?

Men and women experiencing low sexual desire (HSDD), reduced libido, or sexual arousal difficulties who want a centrally-acting treatment that addresses desire rather than just the physical mechanics of sexual function.

Starting from $199/month

Serving Ohio

Ohio is the heart of it all—manufacturing and medicine, agriculture and innovation, world-class cities and charming small towns. OmniRx Health serves every Buckeye. From the corporate corridors of Columbus to the medical excellence of Cleveland, the cultural richness of Cincinnati to the college towns and farming communities throughout, our telehealth platform fits your Ohio lifestyle. Get expert care without fighting I-71 traffic or waiting weeks for an appointment.

Our providers are licensed by the State Medical Board of Ohio for comprehensive telehealth services statewide.

Ohio's extensive pharmacy network in Columbus, Cleveland, Cincinnati, and throughout the state ensures rapid prescription access.

Ohio has telehealth laws that support virtual care delivery while ensuring patient safety and provider accountability.

Ohio requires telehealth coverage parity for commercial insurers and has expanded Medicaid virtual care coverage.

Frequently Asked Questions

How does PT-141 work differently from Viagra or Cialis?: PDE5 inhibitors like sildenafil and tadalafil work by increasing blood flow to the genitals — they improve physical erectile function but do not enhance sexual desire. PT-141 activates melanocortin receptors in the brain that regulate sexual motivation and arousal, addressing the psychological and neurological dimension of sexual response that PDE5 inhibitors do not target.
Can women use PT-141?: Yes. PT-141 was originally developed in part to address hypoactive sexual desire disorder (HSDD) in women. Vyleesi (bremelanotide injection) is FDA-approved for premenopausal women with HSDD. It has also demonstrated benefits in men with situational erectile dysfunction related to low desire or performance anxiety.
How and when is PT-141 administered?: PT-141 is administered as a subcutaneous injection, typically 45 minutes to 2 hours before anticipated sexual activity to allow sufficient time for central nervous system activation. The injection site is typically the abdomen. Nausea is the most commonly reported side effect and is usually mild and temporary.
Is telehealth legal in Ohio?: Yes, telehealth is fully legal in Ohio. The state supports virtual healthcare delivery, allowing licensed providers to offer consultations, prescriptions, and ongoing care.
Can Ohioans in all three C's cities use telehealth?: Absolutely. Whether you're in Columbus, Cleveland, or Cincinnati, telehealth provides convenient access to care without the urban traffic and parking challenges.
Does Ohio Medicaid cover telehealth?: Yes, Ohio Medicaid covers telehealth services for eligible members. The state has expanded virtual care coverage to improve healthcare access.